课题基金 / 基金详情

Exploring the selectivity and consequences of GPCR homo and hetero- dimerisation/oligomerisation using RASSLs

Exploring the selectivity and consequences of GPCR homo and hetero- dimerisation/oligomerisation using RASSLs
使用 RASSSL 探索 GPCR 同源和异源二聚化/寡聚化的选择性和后果
批准号:
BB/E006302/1
负责人:
Graeme Milligan
金额:
$53.05万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2007
资助国家:
英国
项目状态:
已结题
起止时间:
2007 至 --

项目摘要

项目成果

Graeme Milligan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
G protein-coupled receptors (GPCRs) are the largest family of proteins that transmit signals from the outside of cells to the inside. They are also the targets for a wide range of small molecule medicines developed and produced by the pharmaceutical industry. It has become increasingly clear that GPCRs can exist as dimers or higher-order oligomers and this appears to be integral to their function. Because a wide range of different GPCRs are expressed by individual cells, then it is probable that as well as dimers or oligomers consisting of two of more copies of the same GPCR, 'hetero-dimers' that consist of pairs of different GPCRs are present in cells. It is likely that these will function and be regulated in a distinct manner to homo-dimers consisting of two identical GPCRs. It is difficult to examine different roles of the two elements of a homo-dimer because they bind and respond to the same ligand and this is also true for hetero-dimers between pairs of highly related GPCRs. However, mutagenesis of GPCRs can produce forms of GPCRs generally called Receptors Activated Solely by Synthetic Ligands (RASSLs). I will use RASSLs for the group of GPCRs that respond to acetylcholine to examine these questions. I will also refine and further develop methods we have developed that allow us to predict which GPCRs are able to interact to form hetero-dimers and which are not. Finally, I also plan to develop novel techniques to 'see' whether GPCRs in living cells are organised only as dimers or may form larger, oligomeric structures.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/2193-1801-4-s1-l21
发表时间: 2015
期刊: SpringerPlus
影响因子: --
作者: [Georgoussi Z]
通讯作者: Georgoussi Z
DOI: 10.1124/mol.111.074674
发表时间: 2011-12-01
期刊: MOLECULAR PHARMACOLOGY
影响因子: 3.6
作者: [Alvarez-Curto, Elisa, Prihandoko, Rudi, Milligan, Graeme]
通讯作者: Milligan, Graeme
Heterodimerisation of G protein-coupled receptors: implications for drug design and ligand screening.
G 蛋白偶联受体的异二聚化:对药物设计和配体筛选的影响。
DOI: 10.1517/17460441003720467
发表时间: 2010
期刊: Expert opinion on drug discovery
影响因子: 6.3
作者: [Saenz Del Burgo L]
通讯作者: Saenz Del Burgo L
DOI: 10.1016/j.neuropharm.2017.11.023
发表时间: 2018-07-01
期刊: Neuropharmacology
影响因子: 4.7
作者: [Marsango S, Ward RJ, Alvarez-Curto E, Milligan G]
通讯作者: Milligan G
GPR35: mechanisms of action and agonism as a potential therapeutic strategy for non-alcoholic fatty liver diseases
  • 批准号:
    MR/X008827/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $100.05万
  • 财政年份:
    2024
  • 负责人:
    Graeme Milligan
  • 依托单位:
India Link: Selective interactions between G protein-coupled receptors and conformationally selective arrestin variants
  • 批准号:
    BB/T018720/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $1.98万
  • 财政年份:
    2023
  • 负责人:
    Graeme Milligan
  • 依托单位:
Receptors for Short Chain Fatty Acids in the control of bacterial infection and gut immunity
  • 批准号:
    BB/X001814/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $80.75万
  • 财政年份:
    2022
  • 负责人:
    Graeme Milligan
  • 依托单位:
Molecular and patho-physiological analysis of the G protein-coupled receptor GPR84
  • 批准号:
    BB/T000562/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $114.86万
  • 财政年份:
    2020
  • 负责人:
    Graeme Milligan
  • 依托单位:
海外基金